PharmacyCodes



NutropinAQ (Genentech Inc.) en es it fr

NutropinAQ (Genentech Inc.) Brand names, NutropinAQ (Genentech Inc.) Analogs

NutropinAQ (Genentech Inc.) Brand Names Mixture

  • No information avaliable

NutropinAQ (Genentech Inc.) Chemical_Formula

C990H1532N262O300S7

NutropinAQ (Genentech Inc.) RX_link

http://www.rxlist.com/cgi/generic3/nutropin.htm

NutropinAQ (Genentech Inc.) fda sheet

NutropinAQ (Genentech Inc.) msds (material safety sheet)

NutropinAQ (Genentech Inc.) Synthesis Reference

No information avaliable

NutropinAQ (Genentech Inc.) Molecular Weight

22129.0

NutropinAQ (Genentech Inc.) Melting Point

76 oC at pH 3.5 (Gomez-Orellana, I. et al., Protein Sci. 7:1352-1358 (1998).

NutropinAQ (Genentech Inc.) H2O Solubility

No information avaliable

NutropinAQ (Genentech Inc.) State

Liquid

NutropinAQ (Genentech Inc.) LogP

-0.411

NutropinAQ (Genentech Inc.) Dosage Forms

Solution (Subcutaneous Injection); Powder for solution

NutropinAQ (Genentech Inc.) Indication

For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss

NutropinAQ (Genentech Inc.) Pharmacology

Used in the treatment of dwarfism and growth failure, growth hormone (hGH) stimulates skeletal growth in pediatric patients with growth failure due to a lack of adequate secretion of endogenous GH. Skeletal growth is accomplished at the epiphyseal plates at the ends of a growing bone. Growth and metabolism of epiphyseal plate cells are directly stimulated by GH and one of its mediators, IGF-I (insulin-like growth factor).

NutropinAQ (Genentech Inc.) Absorption

No information avaliable

NutropinAQ (Genentech Inc.) side effects and Toxicity

No information avaliable

NutropinAQ (Genentech Inc.) Patient Information

BIOD00086.html

NutropinAQ (Genentech Inc.) Organisms Affected

Humans and other mammals